Chromophore-Modified Bisnaphthalimides:  DNA Recognition, Topoisomerase Inhibition, and Cytotoxic Properties of Two Mono- and Bisfuronaphthalimides

  • Christian Bailly
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Carolina Carrasco
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Alexandra Joubert
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Christine Bal
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Nicole Wattez
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Marie-Paule Hildebrand
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Amélie Lansiaux
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Pierre Colson
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Claude Houssier
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Monica Cacho
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Ana Ramos
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain
  • Miguel F. Braña
    INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Biospectroscopy and Physical Chemistry Unit, Department of Chemistry and Natural and Synthetic Drugs Research Center, University of Liege, Sart-Tilman, 4000 Liege, Belgium, and Departamento de CC. Químicas, Facultad de CC Experimentales y de la Salud, Universidad San Pablo-CEU, Urb. Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain

収録刊行物

  • Biochemistry

    Biochemistry 42 (14), 4136-4150, 2003-03-21

    American Chemical Society (ACS)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ